State Rep. David Rutigliano (R-123) recently testified in the Insurance and Real Estate Committee in favor of a proposal to stop insurers from denying coverage or charging a higher premium if an individual has previous claims histories concerning Naloxone Hydrochloride (Narcan). Narcan is a drug that can be administered to reverse an opioid overdose.

Rutigliano said he was pleased by the positive reception HB-6087, An Act Restricting the Use of Prior Claims Histories Concerning Naloxone Hydrochloride, received from members of the Insurance Committee during the public hearing.
“We are receiving reports that some people who have filled the prescription for Narcan are being denied life insurance and disability insurance or are being quoted an increased rate for health insurance,” Rutigliano said. “State residents are being red-flagged for possible drug addiction or simply ‘use of drugs.’ We must educate that Narcan cannot be self-administered. It is one of the only prescriptions that you have to have filled for others.”
According to Rutigliano, Connecticut has been encouraging people to carry Narcan and has made it available to first responders in the general public.
“We believe the people should be encouraged to carry this life-saving drug and we ask that you remove what could be a potential barrier to this goal,” Rutigliano said during the hearing. “Our neighboring state of Massachusetts has recently taken action advising life and disability insurers not to deny coverage to Good Samaritans who carry the overdose reversal drug.”